Investors building global equity exposure frequently weigh how much currency risk, market breadth, and cost they are willing to accept. HEFA and VEA sit at opposite ends of that spectrum even though both target developed international equities. HEFA is a currency-hedged, large- and mid-cap fund limited to Europe, Australasia, and the Far East. VEA is an unhedged, all-capitalization fund spanning developed markets outside the United States, including Canada. They are not direct competitors in a narrow sense; rather, they represent two different answers to the same question — how to own international stocks in a portfolio. Comparing them clarifies trade-offs that are especially relevant in a period of shifting currency regimes, divergent central-bank policies, and sector rotation across global markets. I also checked this using Tickeron’s AI Screener to see how the two compare across key metrics.
HEFA seeks to track the MSCI EAFE 100% Hedged to USD Index, which provides exposure to large- and mid-capitalization equities in developed markets across Europe, Australasia, and the Far East while mitigating fluctuations between the value of those component currencies and the U.S. dollar. The fund is structured as a fund of funds: its dominant holding is the iShares MSCI EAFE ETF (EFA), supplemented by currency forward contracts that neutralize yen, euro, pound, and other foreign-currency exposure. The underlying index comprises roughly 800 holdings.
Top underlying positions include ASML Holding, Novo Nordisk, SAP, Nestlé, Toyota Motor, AstraZeneca, Roche, Novartis, Shell, and LVMH. Sector allocation leans toward Financials (roughly 24–25%), Industrials (about 18–19%), Technology (around 10–11%), and Health Care (near 10%). The net expense ratio is approximately 0.35%, reflecting the additional cost of currency hedging. HEFA is a passively managed, currency-hedged vehicle best suited to investors who want international equity returns without foreign-exchange volatility.
VEA seeks to track the FTSE Developed All Cap ex U.S. Index, a market-capitalization-weighted benchmark of large-, mid-, and small-cap companies across developed markets outside the United States. Unlike HEFA, VEA includes Canada and retains full exposure to foreign-currency movements. The fund holds roughly 3,900 securities, making it one of the broadest and most liquid international equity ETFs available. Its expense ratio is approximately 0.03%, among the lowest in the category.
Top holdings include Samsung Electronics, SK Hynix, ASML Holding, HSBC Holdings, Roche, Shell, Royal Bank of Canada, Novartis, Nestlé, and AstraZeneca. Sector exposure is led by Financials (roughly 22–24%), Industrials (about 17–18%), Technology (around 16–17%), Health Care (near 8%), and Basic Materials (about 7%). Because VEA includes Asian semiconductor leaders, its technology weighting is meaningfully higher than HEFA's. The fund is passively managed and reflects a pure beta approach to developed international equities.
Both funds are shaped by the same global macro forces. Divergent monetary policy between the U.S. Federal Reserve, the European Central Bank, the Bank of Japan, and other central banks has kept currency markets volatile, which matters more to an unhedged fund like VEA. Meanwhile, the artificial-intelligence and semiconductor investment cycle has lifted Asian and European technology names, a tailwind VEA captures more directly through its higher technology weighting. European banks and industrials have also benefited from re-rating cycles and resilient earnings, supporting the Financials-heavy tilt shared by both funds. Key risks include a stronger U.S. dollar — which pressures VEA's unhedged returns — geopolitical tensions, and concentration in a handful of mega-cap technology and financial names. Investors are weighing these catalysts when choosing between hedged and unhedged international exposure.
Over recent weeks and months, relative performance between the two funds has largely tracked the direction of the U.S. dollar. When the dollar strengthens, HEFA's currency hedge tends to cushion returns, while VEA's unhedged exposure detracts. When the dollar weakens, VEA typically gains from foreign-currency appreciation. Beyond currency, VEA's higher technology allocation and inclusion of Canada and small caps have influenced relative positioning during recent market cycles, particularly as semiconductor and AI-related names have led international equity performance. HEFA's heavier concentration in European financials and industrials gives it a different, more cyclical tilt. From a volatility and cost standpoint, VEA's broader diversification and near-zero fee provide structural advantages, while HEFA appeals mainly to investors specifically seeking to remove FX risk from their international allocation. From what I see, running a quick scan in Tickeron’s AI tools helped highlight these positioning differences clearly.
I rely on Tickeron’s AI Screener as part of my routine research process. It lets me filter ETFs by technical patterns, fundamentals, trends, and volatility in a way that speeds up comparisons like this one without replacing my own judgment. The tool surfaces relevant data points quickly so I can focus on the structural factors that matter most for long-term positioning.
Based on observable structural factors, Tickeron's AI would likely favor VEA over HEFA in the current environment. VEA's 0.03% expense ratio versus HEFA's roughly 0.35% represents a durable cost advantage that compounds over time. VEA's far broader diversification — nearly 3,900 holdings versus HEFA's approximately 800 underlying constituents — reduces single-name and single-market risk, and its inclusion of Canada and small caps adds resilience. VEA also carries higher exposure to the technology sector, which has demonstrated relatively stronger trend consistency across recent market cycles. HEFA retains merit as a tactical tool for investors who explicitly want to neutralize currency risk, but on a risk-adjusted, cost-adjusted basis, VEA currently presents the more compelling structural profile.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where VEA declined for three days, in 208 of 259 cases, the price declined further within the following month. The odds of a continued downward trend are 80%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VEA as a result. In 62 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.
The Moving Average Convergence Divergence Histogram (MACD) for VEA turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 35 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
The Aroon Indicator for VEA entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +0.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where VEA advanced for three days, in 266 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
VEA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows